BETA-ADRENOBLOCKERS IN A THERAPEUTIC CLINIC
Abstract
Clinical pharmacology of beta-adrenoblockers within the framework of ATC classification system is described. Clinical classification, pharmacokinetics and pharmacodynamics features of this drug group are given. Clinical application and principles of beta-adrenoblockers use at basic diseases in a therapeutic clinic are examined. Accents on beta-adrenoblockers use in patients with arterial hypertension, ischemic heart diseases and chronic heart failure are made. The main side effects of drugs, absolute and relative contraindications, and interaction with other medications are described.
Downloads
References
2. Документ о соглашении экспертов по блокаторам β-адренергических рецепторов. Рабочая группа Европейского общества кардиологов по бета-блокаторам // Кардиоваскулярная терапия и профилактика. - 2005. - № 1. - С. 99-124.
3. Коваленко В.Н., Свищенко Е.П., Безродна Л.В. Лекарственное лечение артериальной гипертензии. / Под редакцией чл.-корреспондента АМН Украины, профессора Коваленко В.Н. // Библиотека практикующего врача. - 2004. - № 1. - 75 с.
4. Кукес В.Г., Фисенко B.П. Клиническая фармакология блокаторов медленных кальциевых каналов. -М.:Ремедиум, 2003.
5. Национальные рекомендации ВНОК и ОССН по диагностике и лечению ХСН (второй пересмотр). // Сердечная недостаточность. - 2006. - T. 8, № 2. - C. 1-35.
6. Рекомендації Української асоціації кардіологів з діагностики, лікування та профілактики хронічної серцевої недостатності у дорослих.-К.:Четверта хвиля, 2006. - 48 с.
7. Серцево-судинні захворювання. Класифікація, стандарти діагностики та лікування. / За редакцією проф. В.М. Коваленка, проф. М.І. Лутая, проф. Ю.М. Сіренка. Асоціація кардіологів України, 2007. - 128 c.
8. Сіренко Ю.М. Артеріальна гіпертензія. –К.:Моріон, 2002. - 204 с.
9. Яблучанский Н.И. Вдоль обрыва, по-над пропастью... http://www.medicusamicus.com/index.php? action=2x438-3ei-7-8c-13abcdfgh-14arx1
10. Яблучанский Н.И. Коронарный синдром http://www.medicusamicus.com/index.php?action=2x331-7c-9-10-12-13-16-18-19-21-22-23-26-28-32-37-38-39-40-41abop-44x1
11. ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation–executive sum-mary. // EHJ .- 2006. - Vol. 27. - P. 1979-2030.
12. ACC/AHA Guidelines for the Evalution and Management of Chronic Heart Failure in the Adult. A report of the American College of Cardiology // Amer. Heart Association Task Force on Practice Guidelines. – American College of Cardiology and the American Heart Association, Inc, 2001. - Р. 55.
13. 2007 Focused Update of the ACC/AHA 2004 Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction: a report of the American College of Cardiology /American Heart Asso-ciation Task Force on Practice Guidelines: developed in collaboration With the Canadian Cardiovascular Society endorsed by the American Academy of Family Physicians: 2007 Writing Group to Review New Evidence and Update the ACC/AHA 2004 Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction, Writing on Behalf of the 2004 Writing Committee. / Antman EM, Hand M, Armstrong PW, et al // Circulation. -2008. - Vol. 117(2). - P. 296-329.
14. Calvert MJ, Shankar A, McManus RJ, Ryan R, Freemantle N. Evaluation of the management of heart failure in primary care. // Fam Pract. - 2009 Jan 18. [PubMed - as supplied by publisher]
15. Fonarow GC. // Rev Cardiovasc Med. - 2008.- Vol. 9(2).- P. 84-95.
16. Dosing of beta-blocker therapy before, during, and after hospitalization for heart failure (from Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure). / Fonarow GC, Abraham WT, Albert NM, Stough WG et all.// Am J Cardiol. - 2008. - Vol. 102(11). - P. 1524-1529.
17. Gajos G. Diagnostic algorithm and therapeutic options in chronic heart failure: updated review of clinical practice guidelines. // Pol Arch Med Wewn. - 2008. - Vol.118(9). - P.489-500.
18. Gottlieb SS, Fisher ML, Kjekshus J. // Circulation. - 2002. - Vol. 105. - Р. 1182-1188.
19. Groote P, Isnard R, Clerson P, et al // Eur J Heart Fail. - 2009. - Vol. 11(1). - P. 85-91.
20. Guidelines for the prevention, detection and management of chronic heart failure in Australia, 2006. Sydney (Australia): National Heart Foundation of Australia. - 2006, - 79 p.
21. Jessup M, Brozena S.C. // Cardiol Clin. - 2007. - Vol. 25(4). - P. 497-506.
22. Krantz M.J., Tanner J., Horwich T.B., Yancy C. et al // Am J Cardiol. -2008. - Vol. 102(12). -P. 1693-1697.
23. Lainscak M, Moullet C, Schön N, et al // Int J Cardiol. - 2007. - Vol. 122(2). - P. 149-55.
24. London MJ. Beta blockers and alpha-2- agonists for cardioprotection. // Best Pract Res Clin Anaesthesiol. - 2008. - Vol.22(1). - P. 95-110.
25. Luppi F, Franco F, Beghé B, et al // Proc Am Thorac Soc. - 2008. - Vol. 5(8). - P. 848-856.
26. Poole-Wilson PA. // Timely Top Med Cardiovasc Dis. - 2007. - Vol. 11. - E. 2.
27. Setoguchi S, Glynn RJ, Avorn J, et al // Am J Cardiol. - 2007. - Vol. 100(7). - P. 1061-1067.
28. Shah SM, Carey IM, DeWilde S, et al // Br J Gen Pract. - 2008. - Vol. 58(557). - P. 862-869.
29. Zentgraf C, Uebelacker I, Jahns R, et al // Eur J Heart Fail. - 2008. - Vol. 10(12). - P.1236-1245.
30. Straube F, Dorwarth U, Janko S, et al // Herz. - 2008. - Vol. 33(8). - P. 568-579.
31. Waeber B, Feihl F. // Rev Med Suisse. - 2007. - Vol. 3(124). - P. 2003-2004, 2006.
32. Weber M.A., Bakris G.L., Giles T.D., et al // J. Clin Hypertens (Greenwich). - 2008. - Vol. 10(3). - P. 234-238.
33. Wenzel UO, Krebs C. // Curr Hypertens Rep. - 2007. - Vol. 9(6). - P. 491-497.
34. Zidek W. // MMW Fortschr Med. - 2004. - Vol. 146(1-2). - P. 37-38.
The Journal of V. N. Karazin Kharkiv National University, series Medicine has following copyright terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work’s authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal’s published version of the work, with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.